7246 related articles for article (PubMed ID: 19728971)
1. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
2. Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Göttingen minipigs in vivo.
Larsen MO; Rolin B; Sturis J; Wilken M; Carr RD; Pørksen N; Gotfredsen CF
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E670-7. PubMed ID: 16278249
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
4. Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas.
Larsen MO; Rolin B; Gotfredsen CF; Carr RD; Holst JJ
Diabetologia; 2004 Nov; 47(11):1873-8. PubMed ID: 15565374
[TBL] [Abstract][Full Text] [Related]
5. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
6. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes.
Lu L; Zhang Q; Pu LJ; Xu XW; Zhang RY; Zhang JS; Hu J; Yang ZK; Lü AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
Chin Med J (Engl); 2007 Mar; 120(6):479-84. PubMed ID: 17439741
[TBL] [Abstract][Full Text] [Related]
7. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
[TBL] [Abstract][Full Text] [Related]
8. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
9. Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs.
Larsen MO; Juhl CB; Pørksen N; Gotfredsen CF; Carr RD; Ribel U; Wilken M; Rolin B
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E412-21. PubMed ID: 15479954
[TBL] [Abstract][Full Text] [Related]
10. Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs.
Larsen MO; Gotfredsen CF; Wilken M; Carr RD; Pørksen N; Rolin B
Diabetologia; 2003 Feb; 46(2):195-202. PubMed ID: 12627318
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
12. On high-frequency insulin oscillations.
Schmitz O; Rungby J; Edge L; Juhl CB
Ageing Res Rev; 2008 Dec; 7(4):301-5. PubMed ID: 18583199
[TBL] [Abstract][Full Text] [Related]
13. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass.
Takada J; Machado MA; Peres SB; Brito LC; Borges-Silva CN; Costa CE; Fonseca-Alaniz MH; Andreotti S; Lima FB
Metabolism; 2007 Jul; 56(7):977-84. PubMed ID: 17570261
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of beta-cell mass and function in the Göttingen minipig.
Larsen MO; Rolin B; Raun K; Bjerre Knudsen L; Gotfredsen CF; Bock T
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():170-9. PubMed ID: 17919191
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
17. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
18. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
19. A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes.
Ribbing J; Hamrén B; Svensson MK; Karlsson MO
J Clin Pharmacol; 2010 Aug; 50(8):861-72. PubMed ID: 20484615
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
